Argenica Therapeutics LtdASX: AGN

ARG-007 Shows Significant Neuroprotection in Main TBI Study

Feb 4, 2025 at 3:44 AM UTC · Issued by Argenica Therapeutics Ltd

Argenica Therapeutics Ltd has released a press release.

View Attachment